Table 1.
The relationships between the expression of circRPPH1 and clinical characteristics in BC patients.
| Clinical characteristics | Total | circRPPH1 level | P value | |
|---|---|---|---|---|
| High (n = 29) | Low (n = 11) | |||
| Age at diagnosis | ||||
| <60 | 18 | 10 | 8 | 0.040* |
| ≥60 | 22 | 19 | 3 | |
| Molecular subtype | ||||
| Luminal A | 12 | 12 | 0 | 0.018* |
| Luminal B | 19 | 12 | 7 | |
| HER2-positive | 5 | 4 | 1 | |
| TNBC | 4 | 1 | 3 | |
| Stage | ||||
| I and II | 36 | 25 | 11 | 0.560 |
| III and IV | 4 | 4 | 0 | |
| Lymph node status | ||||
| Negative | 35 | 24 | 11 | 0.298 |
| Positive | 5 | 5 | 0 | |
| Recurrence and metastasis | ||||
| No | 38 | 27 | 11 | 1.000 |
| Yes | 2 | 2 | 0 | |
*P < 0.05.
Bold values indicate statistical significance.